CJC-1295
Research chemical — not an approved drug or dietary supplement
This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only — talk to a clinician before considering it.
At a glance
- Best for
- Not established — investigational
- Main caution
- Unapproved long-acting GHRH analog with sustained GH elevation of unknown long-term risk and unregulated purity
What is it
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH) designed to stimulate the pituitary to release growth hormone; the 'DAC' (Drug Affinity Complex) version binds albumin to extend its half-life for sustained GH release. It is proposed to raise GH and IGF-1, and is often combined with a ghrelin-mimetic in research/non-clinical use. Human data are limited to small early-phase pharmacokinetic studies; it is not FDA-approved, has no established long-term safety profile, and is not a dietary supplement. It is sold only 'for research use only.'
Is it worth it for you?
Probably skip if…
- You expect an approved therapy — it is not FDA-approved and is not a supplement
- You would source it from 'research use only' vendors with no purity or sterility controls
- You are not prepared for unknown long-term effects of chronically elevated GH/IGF-1
- You are uncomfortable with self-injection risks such as infection and contamination
- You compete in sport — GHRH analogs and secretagogues are prohibited under WADA rules
Safety
Common side effects
Reported in limited settings: injection-site reactions (redness/itching), flushing, headache, transient water retention
Serious risks
- Unregulated purity, sterility, and dosing of research-grade product
- Unknown long-term effects of sustained GH/IGF-1 elevation, including theoretical risks for insulin resistance and growth of existing tumors
- Injection-related infection and contamination risk
- No clinical monitoring of hormone or glucose levels
Who should avoid it
- Anyone without direct medical supervision
- Pregnancy and breastfeeding
- People with cancer or a history of cancer
- People with diabetes or impaired glucose tolerance (without supervision)
- Competitive athletes subject to anti-doping rules
Pregnancy & breastfeeding
Avoid — no safety data.
Choosing a product
Be skeptical of
- 'Proven' anti-aging, muscle-building, or fat-loss claims in humans
- Vendors selling 'for research use only' product for human injection
- Implying it is a safe or approved substitute for prescription growth hormone
Track CJC-1295 with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research — much of it preclinical or early-stage — not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.